Search results for "digestive"

showing 10 items of 2631 documents

Familial Occurrence of Inflammatory Bowel Disease in Celiac Disease

2003

BACKGROUND The authors have previously reported a possible increased risk of the familial occurrence of Crohn's disease in patients with celiac disease. AIM The aim of the current study was to evaluate in a case-control study the familial occurrence of inflammatory bowel disease (IBD) in first-degree relatives of patients with celiac disease. METHODS One hundred eleven consecutive patients with biopsy-proven celiac disease were interviewed to ascertain whether IBD was present in first-degree relatives. The number of relatives, their ages, and possible IBD status were collected in a questionnaire. When a diagnosis of familial IBD was reported, the diagnosis was checked in the hospital record…

AdultMalemedicine.medical_specialtyPopulationDiseaseGastroenterologyInflammatory bowel diseaseHospital recordsInternal medicinePrevalencemedicineHumansImmunology and AllergyIn patienteducationeducation.field_of_studybusiness.industryGastroenterologyCase-control studyInflammatory Bowel Diseasesmedicine.diseaseUlcerative colitisdigestive system diseasesPedigreeCeliac DiseaseIncreased riskCase-Control StudiesFemalebusinessInflammatory Bowel Diseases
researchProduct

Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery?

2019

Source at http://dx.doi.org/10.3748/wjg.v25.i3.388. BACKGROUND - The clinical presentation of gastroesophageal reflux disease (GERD) shows a large symptom variation also in different intensities among patients. As several studies have shown, there is a large overlap in the symptomatic spectrum between proven GERD and other disorders such as dyspepsia, functional heartburn and/or somatoform disorders. AIM - To prospectively evaluate the GERD patients with and without somatoform disorders before and after laparoscopic antireflux surgery. METHODS - In a tertiary referral center for foregut surgery over a period of 3 years patients with GERD, qualifying for the indication of laparoscopic antire…

AdultMalemedicine.medical_specialtyPsychometricsFundoplicationDiseaseLaparoscopic fundoplicationGastroesophageal reflux disease03 medical and health sciencesYoung Adult0302 clinical medicineQuality of lifeInternal medicineVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Gastroscopic surgery: 781medicineHumansddc:610Prospective StudiesYoung adultAntireflux surgeryLaparoscopyProspective cohort studySomatoform DisordersVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologisk kirurgi: 781AgedAged 80 and overmedicine.diagnostic_testbusiness.industryGastroenterologyRefluxGeneral MedicineMiddle Agedmedicine.diseasehumanitiesdigestive system diseasesTreatment OutcomeSomatization030220 oncology & carcinogenesisGERDGastroesophageal RefluxQuality of LifeProspective Study030211 gastroenterology & hepatologyFemaleLaparoscopybusinessSomatizationGastroesophageal reflux disease symptomsWorld Journal of Gastroenterology
researchProduct

Saliva variations in gastro-oesophageal reflux disease.

2007

Abstract Objectives The protective role of saliva in the case of oesophageal exposition to gastric acid has long been studied but some contradictions still remain. The main end-point of this study was to evaluate if a qualitative and quantitative alteration in salivary secretion exists in patients affected by GERD. Methods One hundred and twenty patients (T group) with clinically and endoscopically diagnosed GERD, and 98 healthy subjects (C group) have been evaluated; salivary tests (i.e. basal flow rate, stimulated flow rate, pH, [Na + ] and [K + ]) were performed, socio-demographical variables and oral GERD-related symptoms were taken into account. SPSS 10.5 software was used for statisti…

AdultMalemedicine.medical_specialtySalivaBurning Mouth SyndromeGastroenterologyXerostomiaStatistics NonparametricBasal (phylogenetics)Gastro-Internal medicinemedicineHumansSalivaGeneral DentistryAgedChi-Square Distributionbusiness.industryRefluxCase-control studyMiddle Agedmedicine.diseaseprotective role of salivahumanitiesdigestive system diseasesSurgeryCross-Sectional StudiesCase-Control StudiesGERDGastroesophageal RefluxGastric acidFemalebusinessSecretory RateChi-squared distributionJournal of dentistry
researchProduct

Molecular detection of Helicobacter pylori in oral samples from patients suffering digestive pathologies

2010

Objective: to determine the simultaneous presence of H. pylori in both the oral cavity and gastric mucosal in patients suffering digestive pathologies and to establish the possible association between the presence of H. pylori in the oral cavity and the gingivoperiodontal pathology. Study design: Patients with gastric symptoms (case group) and asymptomatic patients (control group) seen at the Gastroenterology Department of Dr. Julio C. Perrando Hospital (Resistencia, Argentina) were selected. Dental plaque and saliva samples from both groups were obtained. In the case group, gastric biopsy samples were also taken. H. pylori was detected in gastric biopsies by histological stains, and Polyme…

AdultMalemedicine.medical_specialtySalivaPathologyAdolescentDigestive System DiseasesDental PlaqueDiseaseDental plaqueGastroenterologyAsymptomaticlaw.inventionYoung AdultlawInternal medicineMedicineHumansYoung adultRisk factorChildSalivaGeneral DentistryPolymerase chain reactionAgedMouthbiologyHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngologyMolecular Diagnostic TechniquesGastric MucosaChild PreschoolUNESCO::CIENCIAS MÉDICASSurgeryFemalemedicine.symptombusiness
researchProduct

A breathing-retraining procedure in treatment of sleep-onset insomnia: theoretical basis and experimental findings.

1995

Increase in CO2 has a sedative effect upon the central nervous system, and the beginning of sleep coincides with modifications in breathing, decrease in ventilation, and in pCO2 increase. In this paper is described a technique of breathing that is useful in producing drowsiness in a very short time. 46 insomniacs were randomly allocated to either a treatment or control condition. In the former, patients were trained in the breathing process. The control group was taught no breathing process. Latencies to sleep for the insomniacs confirmed that the breathing process was useful in producing drowsiness. Theoretical bases are discussed.

AdultMalemedicine.medical_specialtySedative effectExperimental and Cognitive PsychologyBreathing Exercises050105 experimental psychologylaw.invention03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawSleep Initiation and Maintenance DisordersmedicineInsomniaHumans0501 psychology and cognitive sciencesBreathing retrainingdigestive oral and skin physiology05 social sciences030229 sport sciencesCarbon DioxideSensory SystemsAnesthesiaBreathingFemaleSleep (system call)Sleep Stagesmedicine.symptomSleep onsetPsychologyArousalPerceptual and motor skills
researchProduct

Ultra-long-distance running and the liver.

1990

During an ultra-long-distance race (1000 km in 20 days) the influence of running was examined on the enzymes aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (AP), gamma-glutamyl-transferase (GGT), and glutamate dehydrogenase (GLDH) with regard to their release from the liver cells or their induction. Furthermore the liver synthetic capacity was assayed by measuring the enzyme activity of cholinesterase and the concentration of serum albumin during the race. Of the 110 participants, 55 finished the race and only the results of these runners were used in our study. AP increased continuously from day 0 (mean = 102 U/L) to day 19 (mean = 120 U/L). A fivefo…

AdultMalemedicine.medical_specialtySerum albuminPhysical Therapy Sports Therapy and Rehabilitationdigestive systemRunningInternal medicinemedicineHumansOrthopedics and Sports MedicineSerum AlbuminCholinesteraseAgedchemistry.chemical_classificationAnalysis of VariancebiologyLiver cellGlutamate dehydrogenaseAlbuminMiddle Ageddigestive system diseasesEnzyme assayOxygenEnzymeEndocrinologychemistryLiverEnzyme Inductionbiology.proteinPhysical EnduranceAlkaline phosphataseFemaleLiver CirculationInternational journal of sports medicine
researchProduct

Microcentrifuge or Automated Hematological Analyzer to Assess Hematocrit in Exercise? Effect on Plasma Volume Loss Calculations

2016

The assessment of plasma volume loss (∆PV) induced by exercise can be estimated from changes in hematocrit (Htc) and hemoglobin (Hb), and it is essential when investigating the metabolic or biologic response to exercise of circulating biomarkers. We aimed to ascertain whether the estimation of ∆PV may differ when Hb and Htc are determined by automated hematological analyzer (AHA) versus manual methods. Twenty-five healthy male subjects performed a maximal running incremental exercise. Blood samples were taken before exercise, immediately after exercise, and after a 30-min recovery. Hb and Htc (Htc-AHA) were determined by an AHA. Htc was also determined by microcentrifugation (Htc-M). The ∆P…

AdultMalemedicine.medical_specialtySpectrum analyzerSysmexAnalytical chemistryCentrifugationHematocritPlasma volumeIncremental exerciseHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumanshemoconcentrationhealth care economics and organizationsplasma volumeAutomation LaboratoryexerciseBiologic responsemedicine.diagnostic_testChemistryDill and Costill equation030229 sport sciencesMiddle AgedhemoglobinHemoconcentrationDill and Costill equation; Sysmex; exercise; hemoconcentration; hemoglobin; plasma volumeHealthy Volunteersdigestive system diseasesComputer Science ApplicationsMedical Laboratory TechnologyCirculating biomarkersHematocritCardiologyHemoglobinBiomarkers030215 immunologySLAS Technology
researchProduct

Calf muscle pump impairment and delayed healing of venous leg ulcers: Air plethysmographic findings

2007

There is a need for a diagnostic tool to predict clinical outcome of venous leg ulcer patients, as the prognosis of healing based on clinical data alone has not appeared to be satisfactory. Air plethysmographic assessment of calf muscle pump was performed in the supine and upright position in 129 patients with active ulcers on their legs. All patients were managed in a specialized leg ulcer clinic. Results of air plethysmography were compared to clinical data and time of healing of ulcers. Muscle pump failure was found in 42.6% of extremities (supine position, 33.3%; upright, 22.5%; both, 12.4%). Patients with insufficient pump were older, and their ulcers were larger. Failure of pump was f…

AdultMalemedicine.medical_specialtySupine positionDermatologyVenous leg ulcerVaricose UlcerRisk Factorsleg ulcermedicineHumansPlethysmographVaricose UlcerMuscle SkeletalAgedAged 80 and overWound Healingplethysmographybusiness.industryCalf muscle pumpcalf muscle pumpGeneral MedicineMiddle AgedPrognosismedicine.diseasedigestive system diseasesSurgeryLeg ulcerLower ExtremityVenous InsufficiencyFemalemedicine.symptombusinessDelayed healingMuscle ContractionMuscle contractionThe Journal of Dermatology
researchProduct

Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.

2006

BACKGROUND The efficacy of consensus interferon (CIFN), a synthetic IFN with optimised in vitro activity, was assessed in chronic hepatitis C virus (HCV) patients who had failed the pretreatment with interferon-alpha (IFNalpha) and ribavirin. METHODS One hundred and three patients after non-response (n=69) or relapse (n=34) to IFNalpha+/-ribavirin were randomly assigned to high-dose induction (CIFN 27-->9 microg daily for 24 weeks, 9 microg t.i.w. for 24 weeks) or low-dose treatment (CIFN 18 microg t.i.w. for 12 weeks, 9 microg t.i.w. for 36 weeks); each with ribavirin 800 mg/day. Follow-up was 24 weeks. RESULTS Non-responder patients treated with high-dose induction had higher early virolo…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentConsensus interferonAlpha interferonHepacivirusGastroenterologyAntiviral AgentsVirusVirological responsechemistry.chemical_compoundChronic hepatitisInternal medicineRibavirinMedicineHumansIn patientDosingProspective StudiesAgedHepatologyDose-Response Relationship Drugbusiness.industryRibavirinvirus diseasesInterferon-alphaHepatitis C ChronicMiddle AgedViral Loaddigestive system diseasesTreatment OutcomechemistryResearch DesignImmunologyFemaleInterferonsbusinessBiomarkersFollow-Up StudiesLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks

2011

Guidelines recommend that patients with chronic hepatitis C virus (HCV) infection be treated with pegylated interferon and ribavirin for 24, 48, or 72 weeks, based on their virologic response to treatment. We investigated the effects of treating patients for individualized durations.We treated 398 treatment-naïve patients who had HCV genotype 1 infections with pegylated interferon alfa-2b and ribavirin for 24, 30, 36, 42, 48, 60, or 72 weeks (mean of 39 weeks, termed individualized therapy); the duration of therapy was determined based on baseline viral load and the time point at which HCV RNA levels became undetectable (measured at weeks 4, 6, 8, 12, 24, and 30). Results were compared with…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentGenotypeTranscription-mediated amplificationHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyVirusPolyethylene GlycolsYoung AdultLiver diseasechemistry.chemical_compoundPegylated interferonGermanyInternal medicineRibavirinHumansMedicinePrecision MedicineAgedDose-Response Relationship DrugHepatologybusiness.industryStandard treatmentRibavirinGastroenterologyInterferon-alphavirus diseasesHepatitis C ChronicMiddle Agedmedicine.diseaseRecombinant Proteinsdigestive system diseasesClinical trialTreatment OutcomechemistryImmunologyRNA ViralDrug Therapy CombinationFemalebusinessViral loadmedicine.drugGastroenterology
researchProduct